We found no differences between intervention groups in mean Hb at 36 gw (P = 0.112; Table 2) or prevalence of anaemia (P = 0.104; Table 3) after adjusting for baseline Hb, CRP, and AGP. This evidence concerns the gene ATP5MK and anemia.